Suppr超能文献

CT 影像学中间容积定义了一个纤维化区域,该区域可预测常染色体显性遗传多囊肾病患者肾小球滤过率下降。

Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.

机构信息

Department of Biomedical Engineering, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

出版信息

Am J Pathol. 2011 Aug;179(2):619-27. doi: 10.1016/j.ajpath.2011.04.036. Epub 2011 Jun 17.

Abstract

Total kidney and cyst volumes have been used to quantify disease progression in autosomal dominant polycystic kidney disease (ADPKD), but a causal relationship with progression to renal failure has not been demonstrated. Advanced image processing recently allowed to quantify extracystic tissue, and to identify an additional tissue component named "intermediate," appearing hypoenhanced on contrast-enhanced computed tomography (CT). The aim of this study is to provide a histological characterization of intermediate volume, investigate its relation with renal function, and provide preliminary evidence of its role in long-term prediction of functional loss. Three ADPKD patients underwent contrast-enhanced CT scans before nephrectomy. Histological samples of intermediate volume were drawn from the excised kidneys, and stained with hematoxylin and eosin and with saturated picrosirius solution for histological analysis. Intermediate volume showed major structural changes, characterized by tubular dilation and atrophy, microcysts, inflammatory cell infiltrate, vascular sclerosis, and extended peritubular interstitial fibrosis. A significant correlation (r = -0.69, P < 0.001) between relative intermediate volume and baseline renal function was found in 21 ADPKD patients. Long-term prediction of renal functional loss was investigated in an independent cohort of 13 ADPKD patients, followed for 3 to 8 years. Intermediate volume, but not total kidney or cyst volume, significantly correlated with glomerular filtration rate decline (r = -0.79, P < 0.005). These findings suggest that intermediate volume may represent a suitable surrogate marker of ADPKD progression and a novel therapeutic target.

摘要

全肾和囊肿体积已被用于量化常染色体显性多囊肾病(ADPKD)的疾病进展,但尚未证明其与肾功能衰竭进展有因果关系。先进的图像处理技术最近允许定量测量囊外组织,并识别出一种名为“中间”的额外组织成分,在对比增强 CT(CT)上呈低增强。本研究旨在提供中间体积的组织学特征描述,研究其与肾功能的关系,并初步证明其在功能丧失的长期预测中的作用。三名 ADPKD 患者在肾切除术前接受了对比增强 CT 扫描。从切除的肾脏中提取中间体积的组织样本,并进行苏木精和伊红染色以及饱和苦味酸溶液染色以进行组织学分析。中间体积显示出主要的结构变化,特征为管状扩张和萎缩、微小囊肿、炎症细胞浸润、血管硬化和广泛的肾小管间纤维化。在 21 名 ADPKD 患者中发现相对中间体积与基线肾功能之间存在显著相关性(r = -0.69,P < 0.001)。在 13 名 ADPKD 患者的独立队列中进行了肾功能丧失的长期预测研究,随访时间为 3 至 8 年。中间体积而不是全肾或囊肿体积与肾小球滤过率下降显著相关(r = -0.79,P < 0.005)。这些发现表明,中间体积可能是 ADPKD 进展的合适替代标志物和新的治疗靶点。

相似文献

引用本文的文献

9

本文引用的文献

2
4
Sirolimus therapy to halt the progression of ADPKD.西罗莫司治疗以阻止 ADPKD 的进展。
J Am Soc Nephrol. 2010 Jun;21(6):1031-40. doi: 10.1681/ASN.2009121302. Epub 2010 May 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验